Holter and ECG Changes After Transcatheter Closure Of ASD In Children
Launched by SOHAG UNIVERSITY · Sep 14, 2022
Trial Information
Current as of May 02, 2025
Unknown status
Keywords
ClinConnect Summary
The Aim Of Work:
The focus of this study is to describe the electrocardiography (ECG) changes 1,6,12 months after ASD transcatheter device closure in a pediatric population.
Patients and Method:
* Place of the Study: Cardiac catheterization unit , pediatric department , Sohag university hospital .
* Type of the Study: Prospective observational study.
* Study Period: 12 months (starting from the date of obtaining the approval from the research ethics committee) .
* Patients:
* Inclusion Criteria:
* All children under the age of 18 years diagnosed with ASD , that will undergo transcatheter...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - All children under the age of 18 years diagnosed with ASD , that will undergo transcatheter secundum ASD device closure during the period of the study .
- Exclusion Criteria:
- • - Failure to obtain informed consent .
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials